Posted on January 11, 2011 by Patients and Patents
Ahead of its symposium Wednesday (Medical Innovation at the Crossroads: Choosing the Path Ahead), the Council for American Medical Innovation released a Web video on the impact of medical innovation on American life and its potential (as reported by POLITICO Pulse). The symposium includes U.S. Chief Technology Officer Aneesh Chopra, former House Majority Leader Dick Gephardt, former HHS Secretary Mike Leavitt, PhRMA’s John Castellani and Cleveland Clinic’s Chris Coburn, among others.
PULSE caught up with Aneesh Chopra, Obama’s chief technology officer, who headlines the event, to give us a preview of his Wednesday remarks: “I’m going to make the case that this is the best time and opportunity to work on health care innovation. Between health reform and the recovery act, the conditions, I believe, are ripe for innovation and improvement.”
RT @PatientMatters: Poll : Patients willing to share their personal health info in trials "assuming privacy protections are in place" http:… 22 hours ago
The Promise of American Medical Innovation
Ahead of its symposium Wednesday (Medical Innovation at the Crossroads: Choosing the Path Ahead), the Council for American Medical Innovation released a Web video on the impact of medical innovation on American life and its potential (as reported by POLITICO Pulse). The symposium includes U.S. Chief Technology Officer Aneesh Chopra, former House Majority Leader Dick Gephardt, former HHS Secretary Mike Leavitt, PhRMA’s John Castellani and Cleveland Clinic’s Chris Coburn, among others.
PULSE caught up with Aneesh Chopra, Obama’s chief technology officer, who headlines the event, to give us a preview of his Wednesday remarks: “I’m going to make the case that this is the best time and opportunity to work on health care innovation. Between health reform and the recovery act, the conditions, I believe, are ripe for innovation and improvement.”
Share this:
Filed under: Commentary on news & events, Innovation, North America, Public health Tagged: | Council for American Medical Innovation, global health, Innovation, research and development, research-based pharmaceutical industry, United States of America